Narrative review highlights intranasal corticosteroids and combination therapies for better symptom control in children.
Key messageIntranasal corticosteroids remain the cornerstone treat ment for moderate to severe allergic rhinitis.The 2024-2025 Allergic Rhinitis and its Impact on Asthma guideline update suggests that fixed intranasal antihistamineintranasal corticosteroid combinations may provide greater symptom control in allergic rhinitis than either agent alone.A controlbased patientcentered approach that incorporates realworld evidence is essential for optimizing treatment outcomes in children.
No takes yet. Share an insight, caveat, or question.
Jung Yeon Shim (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: